References
- Centers for Disease Control and Prevention. Selected adverse events reported after COVID-19 vaccination. 2021. [Cited 2021 Oct 24].
- Bischof E, Wolfe J, Klein SL. Clinical trials for COVID-19 should include sex as a variable. J Clin Invest. 2020;130:3350–3352.
- Meredith W. Why coronavirus hits men harder: sex hormones offer clues. Science. 2020 doi:https://doi.org/10.1126/science.abd1288.
- Brady E, Nielsen MW, Andersen JP, et al. Lack of consideration of sex and gender in COVID-19 clinical studies. Nat Commun. 2021;12(1):1–6.
- Schiffer VM, Janssen EB, van Bussel BC, et al. The” sex gap” in COVID-19 trials: a scoping review. EClinicalMedicine. 2020;29-30:100652.
- Palmer-Ross A, Ovseiko PV, Heidari S. Inadequate reporting of COVID-19 clinical studies: a renewed rationale for the Sex and Gender Equity in Research (SAGER) guidelines. BMJ Glob Health. 2021;6(4):e004997.
- Dhakal S, Klein SL. Host factors impact vaccine efficacy: implications for seasonal and universal influenza vaccine programs. J Virol. 2019;93(21):e00797–19.
- Kuo H, Shapiro JR, Dhakal S, et al. Sex-specific effects of age and body mass index on antibody responses to seasonal influenza vaccines in healthcare workers. Vaccine. 2021. DOI:https://doi.org/10.1016/j.vaccine.2021.02.047
- Fischinger S, Boudreau CM, Butler AL, et al. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(2):239–249. Springer Berlin Heidelberg.
- Flanagan KL, Fink AL, Plebanski M, et al. Sex and gender differences in the outcomes of vaccination over the life course. Ann Rev Cell Develop Biol. 2017;33:577–599.
- Puzio A. Why is there such a gender gap in COVID-19 vaccination rates? ABC news. 2021 Jun 22. [Cited 2021 Aug 24]. Available from: https://fivethirtyeight.com/features/why-is-there-such-a-gender-gap-in-covid-19-vaccination-rates/
- Kupferschmidt K, Vogel G. What’s the future of vaccines linked to rare clotting disorders? Science breaks down the latest. Science. May 3 2021. [cited 2021 Aug 24]. Available from: https://www.sciencemag.org/news/2021/05/what-s-future-vaccines-linked-rare-clotting-disorders-science-breaks-down-lates
- Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet. 2021;397:99–111.
- Bendix A. Rare blood clots following both the AstraZeneca and J&J vaccines might be no coincidence — they share the same technology. Insider. 2021 Apr 15. [cited 2021 Oct 23]. Available from: https://www.businessinsider.com/astrazeneca-johnson-and-johnson-rare-blood-clots-similar-2021-4
- Katella K. The Johnson & Johnson vaccine and blood clots: what you need to know. Yale Medicine. 14 Aug 2021. [cited 2021 Oct 23]. Available from: https://www.yalemedicine.org/news/coronavirus-vaccine-blood-clots
- Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against COVID-19 in Israel. N Engl J Med. 2021;385(23):2140–2149.
- Vogel G, Couzin-Frankel J. Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men. Science. 2021 Jun 1. [cited 2021 Aug 23]. Available from: https://www.sciencemag.org/news/2021/06/Israel-reports-link-between-rare-cases-heart-inflammation-and-covid-19-vaccination
- Katella K. Comparing the COVID-19 vaccines: how are they different? Yale Medicine. 2021 Oct 22. [cited 2021 Oct 23]. Available from: https://www.yalemedicine.org/news/covid-19-vaccine-comparison
- World Health Organization. COVID-19 vaccine tracker and landscape. [ Cited 23 Oct 2021]. Available from: https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines
- Fink AL, Klein SL. Sex and gender impact immune responses to vaccines among the elderly. Physiology. 2015;30(6):408–416.
- Fink AL, Klein SL. The evolution of greater humoral immunity in females than males: implications for vaccine efficacy. Curr Opin Physiol. 2018;6:16–20.
- Fischinger S, Boudreau CM, Butler AL, et al. Sex differences in vaccine-induced humoral immunity. Semin Immunopathol. 2019;41(2):239–249.
- Flanagan KL, Fink AL, Plebanski M, et al. Sex and gender differences in the outcomes of vaccination over the life course. Annu Rev Cell Dev Biol. 2017;33:577–599.
- Zimmermann P, Curtis N. Factors that influence the immune response to vaccination. Clin Microbiol Rev. 2019;32:e0084–18.
- Engler RJM. Half- vs full-dose trivalent inactivated influenza vaccine (2004–2005): age, dose, and sex effects on immune responses. Arch Intern Med. 2008;168:2405.
- Sudre CH, Murray B, Varsavsky T, et al. Attributes and predictors of long-COVID: analysis of COVID cases and their symptoms collected by the covid symptoms study app. medRxiv. 2020. published online Oct 21. (preprint). DOI:https://doi.org/10.1101/2020.10.19.20214494.
- Ravindran TS, Teerawattananon Y, Tannenbaum C, et al. Making pharmaceutical research and regulation work for women. BMJ. 2020;371:m3808.
- Brady E, Nielsen MW, Andersen JP, et al. Lack of consideration of sex and gender in clinical trials for COVID-19. medRxiv. 2020; published online Sept 14. (preprint). DOI:https://doi.org/10.1101/2020.09.13.20193680.
- Bignucolo A, Scarabel L, Mezzalira S, et al. Sex disparities in efficacy in COVID-19 vaccines: a systematic review and meta-analysis. Vaccines (Basel). 2021;9(8):825.
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615.
- Baden LR, El Sahly HM, Essink B, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–416.